International Journal of Coronaviruses

International Journal of Coronaviruses

International Journal of Coronaviruses – About

Open Access & Peer-Reviewed

Submit Manuscript

About the International Journal of Coronaviruses

Advancing virology research through rigorous peer-reviewed journal on coronavirus biology, molecular mechanisms, and global surveillance

Dedicated to Coronavirus Science and Viral Pathogen Research

The International Journal of Coronaviruses (IJCV) (ISSN 2692-1537) serves as a specialized peer-reviewed platform for virology researchers investigating coronavirus biology, molecular mechanisms, and viral evolution. Launched in 2020 during the global SARS-CoV-2 emergence, IJCV provides an essential forum for microbiologists, virologists, and public health researchers to disseminate original discoveries on coronavirus genomics, replication strategies, host-pathogen interactions, and zoonotic transmission dynamics.

As an open-access journal aligned with COPE ethical standards, IJCV accelerates the global exchange of evidence-based coronavirus research. Our editorial board comprises leading virologists and microbiologists who ensure rigorous peer review while maintaining rapid publication timelines critical for understanding rapidly evolving viral threats.

2020 Founded During Pandemic
2-4 Weeks Average Review Time
Open Access CC BY 4.0 License
Global Researcher Network
Mission: Advancing Coronavirus Virology

IJCV's core mission centers on providing a trusted publication venue for high-quality research investigating coronavirus biology at molecular, cellular, and population levels. We prioritize studies that illuminate viral genomic architecture, replication mechanisms, protein function, immune evasion strategies, and evolutionary trajectories across coronavirus genera including Alphacoronavirus, Betacoronavirus, Gammacoronavirus, and Deltacoronavirus.

The journal particularly welcomes microbiological investigations into viral-host interactions, receptor binding mechanisms, cell entry pathways, replication organelles, and innate immune responses. By maintaining rigorous peer review standards while ensuring open-access dissemination, IJCV facilitates rapid knowledge translation from laboratory discovery to global research application.

Vision Statement: To establish IJCV as the definitive resource for evidence-based coronavirus virology research, supporting the global scientific community's ability to monitor, understand, and respond to emerging coronavirus threats through rigorous microbiological investigation.
Research Scope: Coronavirus Biology & Microbiology

IJCV publishes original research, systematic reviews, and methodological papers across the full spectrum of coronavirus microbiology. Our scope emphasizes fundamental virology research while incorporating epidemiological surveillance data that informs understanding of viral evolution and transmission patterns.

Viral Genomics & Molecular Biology

Genome structure, organization, variability; RNA replication mechanisms; transcription regulation; viral polymerase function; proofreading mechanisms.

Viral Protein Structure & Function

Spike protein conformational dynamics; receptor binding domains; membrane fusion mechanisms; nucleocapsid assembly; protease function; accessory proteins.

Host-Pathogen Interactions

Receptor recognition; cell entry mechanisms; membrane trafficking; replication compartments; innate immune sensing; interferon responses; immune evasion.

Viral Evolution & Phylogenetics

Mutation dynamics; recombination events; variant emergence; selective pressures; molecular clock analysis; phylogeographic patterns; zoonotic spillover.

Diagnostic Methodologies

PCR optimization; antigen detection; serological assays; sequencing protocols; rapid diagnostics; biosensor development; quality control standards.

Antiviral Mechanisms

Target identification; drug resistance mechanisms; structure-activity relationships; viral enzyme inhibition; entry inhibitors; polymerase inhibitors.

Immunological Responses

Antibody neutralization; T-cell responses; epitope mapping; immune memory; cross-reactivity; immunopathology mechanisms.

Epidemiological Surveillance

Genomic surveillance; transmission dynamics; outbreak investigation; environmental monitoring; wastewater surveillance; spatial epidemiology.

For comprehensive scope details, consult our Aims & Scope page. IJCV accepts original research articles, review manuscripts, short communications, case reports, methodological papers, editorials, data papers / data notes, technical notes, hypothesis / concept papers, rapid communications, mini reviews, conference papers / proceedings, video articles / visualized experiments, book reviews, and letters addressing coronavirus microbiology.

Editorial Leadership & Peer Review Excellence

Professor Rabiul Ahasan

Editor-in-Chief, King Saud University

Professor Ahasan directs IJCV's editorial operations with expertise in occupational health and viral disease surveillance. Under his leadership, the journal maintains rigorous peer review standards through collaboration with international virologists, microbiologists, and public health specialists. The editorial board emphasizes methodological rigor, reproducibility, and translational significance in evaluating coronavirus research submissions.

Explore the full editorial board at the IJCV Editorial Board page.

Rigorous Single-Blind Peer Review Process

IJCV employs comprehensive single-blind peer review conducted by subject matter experts in virology, microbiology, and related disciplines. Each submission undergoes:

1

Initial Submission & Plagiarism Screening

Manuscripts are logged and screened for originality using iThenticate plagiarism detection software to ensure academic integrity.

2

Editorial Scope Assessment

Editor-in-Chief evaluates alignment with journal scope, methodological soundness, and potential contribution to coronavirus virology.

3

Expert Peer Review Assignment

2-3 external reviewers with specialized expertise assess scientific rigor, experimental design, data interpretation, and conclusions.

4

Reviewer Evaluation & Recommendations

Reviewers provide detailed feedback on methodology, statistical analysis, figure quality, and manuscript clarity with revision recommendations.

5

Editorial Decision Communication

Authors receive decision (accept, minor/major revisions, reject) with consolidated reviewer feedback and revision timeline.

6

Revision Submission & Re-review

Authors address reviewer comments; revised manuscripts undergo verification of changes before final acceptance.

7

Production & Online Publication

Accepted manuscripts undergo professional formatting, proofreading, DOI assignment, and rapid online publication.

IJCV's peer review process prioritizes scientific integrity through adherence to COPE guidelines and international publication ethics standards. Learn more at our Publication Ethics page.

Research Integrity & Ethical Standards

IJCV maintains unwavering commitment to research integrity, data transparency, and ethical publishing practices aligned with Committee on Publication Ethics (COPE) principles.

  • Originality Verification: All submissions undergo plagiarism screening to ensure original scholarship and proper attribution.
  • Data Transparency: Authors must provide access to underlying datasets, protocols, and analytical code when feasible to support reproducibility.
  • Ethical Compliance: Research involving human subjects or animal models requires institutional ethics approval documentation.
  • Conflict of Interest Disclosure: Authors, reviewers, and editors must declare financial or personal relationships that could influence objectivity.
  • Authorship Attribution: Manuscripts must document author contributions using CRediT taxonomy ensuring appropriate credit allocation.
Open Science Commitment: IJCV encourages preprint deposition, data sharing via public repositories (GenBank, GISAID, Protein Data Bank), and protocol registration to enhance research transparency and reproducibility.
Open Access Publishing & Author Rights

IJCV publishes all content under Creative Commons Attribution 4.0 International (CC BY 4.0) license, ensuring immediate worldwide access without subscription barriers. Authors retain copyright while granting unlimited reuse rights with proper attribution.

Author Benefits

  • Rapid publication timelines (2-4 weeks typical review)
  • Global visibility through open-access distribution
  • Permanent DOI assignment via CrossRef
  • Unrestricted reuse rights for teaching and derivatives
  • Indexing in major academic databases

Article processing charges apply only upon acceptance. View pricing details and waiver eligibility at our APC information page.

Indexing & Global Visibility

IJCV articles are indexed across major academic databases and discovery platforms to maximize research impact:

Google Scholar
CrossRef
DOAJ
Academic Databases
Open Policy Finder
Semantic Scholar

Each published article receives permanent DOI registration enabling persistent citation tracking and long-term archival preservation. IJCV actively submits content to specialized virology and microbiology databases to connect research with target audiences.

Collaborative Research Network

IJCV authors represent leading virology laboratories, public health institutes, and microbiology departments worldwide. Recent publications have originated from King Saud University, Harvard Medical School, University of Oxford, National University of Singapore, University of Tokyo, and Max Planck Institute, reflecting the journal's international reach across coronavirus research communities.

Special Issue Opportunities: IJCV welcomes proposals for thematic special issues addressing focused topics in coronavirus virology. Interested guest editors should contact [email protected] with topic proposals and contributor lists.

Contribute to Coronavirus Virology Research

Join the global scientific community advancing understanding of coronavirus biology, evolution, and host interactions through rigorous peer-reviewed publication.

Contact IJCV Editorial Office: For submission inquiries, scope questions, or editorial matters, contact [email protected]. Our editorial team responds to all queries within 48-72 hours.